Related Experiment Video
Updated: Jul 19, 2026
20:38
Isolation and Transplantation of Hematopoietic Stem Cells (HSCs)
Published on: February 25, 2007
Current status of haploidentical stem cell transplantation
Bimalangshu R Dey1, Thomas R Spitzer
1Bone Marrow Transplant Program, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
British Journal of Haematology
|September 21, 2006
Summary
Haploidentical stem cell transplants offer an alternative when matched donors are unavailable. Advances in T-cell depletion and transplant strategies aim to reduce graft-versus-host disease and improve patient outcomes.
Area of Science:
- Hematology
- Immunology
- Transplantation Medicine
Background:
- Haploidentical stem cell transplantation (HSCT) is a viable option for patients lacking a human leucocyte antigen (HLA)-matched donor.
- Historically, HSCT faced challenges including graft-versus-host disease (GVHD), graft rejection, and poor immune reconstitution due to the major histocompatibility barrier.
Purpose of the Study:
- To review the evolution and current strategies in haploidentical stem cell transplantation.
- To discuss the immunological challenges and advancements in mitigating risks associated with HSCT.
Main Methods:
- Review of historical and current literature on haploidentical stem cell transplantation.
- Analysis of different graft manipulation techniques, including T-cell depletion.
- Evaluation of myeloablative and non-myeloablative transplant strategies.
Main Results:
- Ex vivo T-cell depletion reduces GVHD but increases risks of engraftment failure and relapse.
- Myeloablative strategies with T-cell-depleted stem cells show promise in acute leukemia.
- Non-myeloablative strategies inducing mixed chimerism offer potential for limiting GVHD and mortality.
Conclusions:
- Haploidentical stem cell transplantation has evolved significantly, offering improved outcomes.
- Future directions include selective allodepletion and post-transplant immunomodulation.
- Continued research aims to optimize HSCT for broader patient applicability.
Related Concept Videos
01:22Bone Marrow Sampling and Transplants
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
01:19Multipotency of Hematopoietic Stem Cells
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
01:24Tissue Transplantation
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
01:21Stem Cell Therapy for Tissue Regeneration
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
00:57Embryonic Stem Cells
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...